Biotech Investors & VC Firms in France

77 firms in this list, with a median first check of $540K. 19 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
BL Blue Horizon Corporation LBTK2 people · Follows rounds	88🔒	Zurich	CH	Pre-Seed–Late Stage	—	+ Add to CRM
GI Gilde Healthcare AFEDGPHD24 people · Follows rounds	88🔒	Utrecht	NL	Seed–Late Stage	$1.1M – $55M	+ Add to CRM
FO Forepont Capital Partners DPDWACAC24 people · Leads rounds	88🔒	New York	US	Pre-Seed–Late Stage	—	+ Add to CRM
TV TVM Capital HBLMMRSF22 people · Leads rounds	88🔒	Munich	DE	Seed–Late Stage	$1.1M – $16.2M	+ Add to CRM
OV OVNI Capital ALASMOEE11 people · Leads rounds	88🔒	San Francisco	US	Pre-Seed–Series A	$250K – $2M	+ Add to CRM
ST Starquest Capital ADEGHDOK14 people	88🔒	Paris	FR	Seed–Growth	$530K – $21.2M	+ Add to CRM
BI Big Pi Ventures AEADGKMV19 people · Leads rounds	88🔒	Athens	GR	Pre-Seed–Growth	$540K – $3.2M	+ Add to CRM
LA Lauxera Capital Partners ASPMSLEF16 people · Leads rounds	88🔒	Paris	FR	Growth–Late Stage	$22M – $110M	+ Add to CRM
BL Blue Wire Capital ATBHJTKZ6 people · Follows rounds	88🔒	London	GB	Pre-Seed–Series A	$50K – $300K	+ Add to CRM
IN Invivo Capital Partners AFLPGGBC11 people	88🔒	Barcelona	ES	Pre-Seed–Series A	$2.2M – $4.3M	+ Add to CRM
DE Debiopharm Innovation Fund MCTMTGVL13 people · Leads rounds	88🔒	Lausanne	CH	Pre-Seed–Late Stage	$1M – $5M	+ Add to CRM
CA Capital Cell	88🔒	Barcelona	ES	Pre-Seed–Growth	—	+ Add to CRM
CL Clay Capital MDMVAMGC16 people	88🔒	—	SG	Seed–Late Stage	$3M – $8M	+ Add to CRM
AM AMR Action Fund HSMHJGBB13 people	88🔒	Boston	US	Seed–Series C	—	+ Add to CRM
AU Auriga Partners JCCLGRMC15 people	88🔒	Paris	FR	Seed–Growth	$540K – $5.4M	+ Add to CRM
GO GO Capital AMAMBDDL13 people	88🔒	Saint Jacques de la Lande	FR	Seed–Series B	$162K – $2.2M	+ Add to CRM
PU Pureos Bioventures DEKBMMVG11 people	88🔒	Pfäffikon	CH	Seed–Series C	—	+ Add to CRM
NO Novalis Biotech JVWVKMJB9 people	88🔒	Ghent	BE	Pre-Seed–Series A	—	+ Add to CRM
EL Elysia Capital MLSBFMFB7 people	88🔒	Turin	IT	—	—	+ Add to CRM
AN Angels Santé AJAGCMEP12 people	88🔒	Paris	FR	Pre-Seed–Series A	—	+ Add to CRM
PA PAI Partners AAAAEAEA8 people	88🔒	Paris	FR	Growth–Late Stage	$108M – $324M	+ Add to CRM
AE Aescap Life Sciences PKPDBJGH14 people	88🔒	Amsterdam	NL	Seed–Growth	—	+ Add to CRM
SO Sodero AACVMSRE11 people	88🔒	Nantes	FR	Seed–Late Stage	$162K – $5.4M	+ Add to CRM
PO Positron Ventures GVJPASML8 people	88🔒	Amsterdam	NL	Pre-Seed–Series A	—	+ Add to CRM

Blue Horizon Corporation

ZurichPre-Seed–Late Stage

LBTK2 people

Gilde Healthcare

UtrechtSeed–Late Stage$1.1M – $55M

AFEDGPHD24 people

Forepont Capital Partners

New YorkPre-Seed–Late Stage

DPDWACAC24 people

TVM Capital

MunichSeed–Late Stage$1.1M – $16.2M

HBLMMRSF22 people

OVNI Capital

San FranciscoPre-Seed–Series A$250K – $2M

ALASMOEE11 people

Starquest Capital

ParisSeed–Growth$530K – $21.2M

ADEGHDOK14 people

Big Pi Ventures

AthensPre-Seed–Growth$540K – $3.2M

AEADGKMV19 people

Lauxera Capital Partners

ParisGrowth–Late Stage$22M – $110M

ASPMSLEF16 people

Blue Wire Capital

LondonPre-Seed–Series A$50K – $300K

ATBHJTKZ6 people

Invivo Capital Partners

BarcelonaPre-Seed–Series A$2.2M – $4.3M

AFLPGGBC11 people

Debiopharm Innovation Fund

LausannePre-Seed–Late Stage$1M – $5M

MCTMTGVL13 people

Capital Cell

BarcelonaPre-Seed–Growth

Clay Capital

Seed–Late Stage$3M – $8M

MDMVAMGC16 people

AMR Action Fund

BostonSeed–Series C

HSMHJGBB13 people

Auriga Partners

ParisSeed–Growth$540K – $5.4M

JCCLGRMC15 people

GO Capital

Saint Jacques de la LandeSeed–Series B$162K – $2.2M

AMAMBDDL13 people

Pureos Bioventures

PfäffikonSeed–Series C

DEKBMMVG11 people

Novalis Biotech

GhentPre-Seed–Series A

JVWVKMJB9 people

Elysia Capital

Turin

MLSBFMFB7 people

Angels Santé

ParisPre-Seed–Series A

AJAGCMEP12 people

PAI Partners

ParisGrowth–Late Stage$108M – $324M

AAAAEAEA8 people

Aescap Life Sciences

AmsterdamSeed–Growth

PKPDBJGH14 people

Sodero

NantesSeed–Late Stage$162K – $5.4M

AACVMSRE11 people

Positron Ventures

AmsterdamPre-Seed–Series A

GVJPASML8 people

Data sourced from public filings and firms' own websites — see our methodology.